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Purpose: To investigate the efficacy and safety of Genipin and UV-riboflavin crosslinking (UV-CLX) in corneal
crosslinking.
Methods: Porcine eyes were separated in groups for each crosslinker, genipin 0.25% UV-CLX (clinical crosslinking
procedure), glutaraldehyde 0.1% (gold standard crosslinker), and control eyes. Intraocular pressure (IOP) was continuosly
monitored by a pressure sensor cannulated to the anterior chamber and the volume was changed. The changes in ocular
pressure as a function of change of the ocular volume were evaluated. Ocular rigidity was calculated as the exponential
of polynomial quadratic fit. Endothelial damage was evaluated in a viability assay with alizarin red staining as the changes
in cell counts.
Results: Significant changes in IOP were observed in the globes were the cornea was stiffened with genipin and UV-CLX
treatment (volume 200 μl: Genipin 19.4 mmHg, UVCRX 18.8 mmHg, glutaraldehide 23.9 mmHg, versus control
14.7  mmHg,  and  400  μl  genipin  31.5  mmHg,  UV-CLX  26.0  mmHg,  glutaraldehide  37.3  mmHg  versus  control
18.7  mmHg).  The  mean  ocular  ridigity  coefficient  was  genipin  0.0078  mmHg/μl,  UV-CLX  0.0065  mmHg/μl,
glutaraldehide 0.0092 mmHg/μl, and 0.0046 mmHg/μl for control eyes. Endothelial cell damage was 5.9±1.8% (control),
10.3±1.7% (UV-CLX), 9.4±1.5% (Genipin 0.25%), and 40.1±6.2% (glutaraldehide). Some granules were observed in the
UV-CLX group. Reduction of keratocites was observed in the UV CRX crosslinking.
Conclusions: Corneal crosslinking was similar between UV-CLX and genipin with minimal toxicity to endothelial cells.
Stiffened corneas by any method induced substancially higher IOP elevation when ocular volume is increased.
Collagen crosslinking has emerged as a method for the
treatment of corneal ectasia [1]. In the clinical setting UV
riboflavin (UV-CLX) [2] has become as the standard in the
treatment  of  keratoconic  eyes,  however  UV-CLX  implies
corneal and eye UV irradiation so others systems have been
proposed (Genipin, nitroalcohols) [3,4]. Genipin, the active
molecule  derived  from  Gardenia  jazminoides,  has  been
proposed as a alternative crosslinking method showing an
increase  in  the  biomechanical  of  the  cornea  in  vitro  and
increase  of  the  resistance  of  the  cornea  to  enzymatic
degradation [3], since UV is not required one could consider
that the toxicity is lower. We conducted this study to compare
genipin with UV-CLX and we evaluated cytotoxic effects in
endothelial cells and keratocytes of both treatments in a ex
vivo model.
Actual methods of calculating increase in stiffness are
based in tensile stress tests, this methods implies cutting the
tissue from the sclera and measuring forces in a unidirectional
direction,  thus  the  stresses  are  not  distributed  in  several
directions, as in vivo, also the tissue is mounted and the ends
of  the  sample  can  induce  some  deformation  altering  the
results, so a method to measure must have to count with all
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this  difficulties,  especially  when  treatments  are  compared
[5]. Whole globe pressure tests overcomes this difficulties and
methodology  like  this,  have  been  used  to  evaluate  ocular
rigidity  and  corneal  stiffness.  To  evaluate  the  effect  of
different cross linkers, the relationship between IOP/volume
is calculated and the ocular rigidity is determinated [6], so
when the cornea is crosslinked the rigidity is increased and
this parameter can be calculated in a physiologic range.
Friedenwald [7] introduced the concept of ocular rigidity
to determinate the relationship between volume and pressure,
this relation gives a estimate of the resistance to the eye to the
distensibility, thus if the eye is stiffened the resistance is
higher. In this study the biomechanical effects of genipin were
compared  with  UV-  CLX  and  with  glutaraldehyde  for
crosslinking, and the effects in the endothelium were also
evaluated in a whole model eye.
METHODS
Eye preparation: Eighty enucleated porcine eyes with clear
corneas were obtained from the local abattoir within 8 to 10
h post-mortem.
Crosslinking methods:
Genipin crosslinking—Genipin is disolved in a isotonic
medium  (PBS)  with  a  customized  vehicle  at  a  0.25%  of
genipin, then was applied as a droplet every 5 min to a porcine
eye in the corneal surface without epithelium (n=20) for 20
min.
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1068UV-CLX—Cornea epithelium (n=20) was removed by
scraping  the  corneal  surface  and  then  the  cornea  is
impregnated with a solution containing 0.1% riboflavin in
20% dextran T500 (Medio Cross, Kiel, Denmark) for 30 min,
followed by 20 min of UVA exposure (370 nm, 3mW/cm2)
obtained with 2 LEDs (Nitride semiconductors, Tokushima,
Japan), a drop is applied every 5 min during the exposure.
Glutaraldehyde crosslinking—Glutaraldehyde at 0.1%
was applied in the corneal surface for 20 min as a droplet every
5 min and then were washed with saline solution for 15 min
(n=20)
Controls eyes—Whole fresh eyes were canulated for the
pressure measurements (n=20).
Pressure measurements: Eyes were canulated in the anterior
chamber, one needle was conected to the infussion system
with BSS and the other needle was conected to a pressure
transductor connected to a digital converter signal, and a trace
of the pressure is obtained (Figure 1). Volume was injected
with a pressure pump until a pressure of 10 mmHg is achieved
and then 200 μl of volume steps were injected every 5 min.
The pressure was monitored continuously (Figure 2). Then the
relationship between volume and pressure is obtained and the
ocular rigidity is calculated as the exponential of quadratic fit.
Endothelial  evaluation—A  diferent  set  of  treated
corneas (n=14 per group) were dissected, carefully mounting
the whole eye in a artificial chamber with the cornea upper,
then the stroma was carefully dissected with a crescent blade
and  the  Descemet  membrane  was  isolated  and  transfered
carefully to a microscope slide and then was stained with red
alizarin at 0.2% in BSS for 2 min and then was washed carefull
Figure  1.  Schematic  of  IOP  –volume
evaluation  in  porcine  eyes,  a  double
cannulation of examined eye is done.
One cannula is connected to the pressure
transducer  and  the  second  one  is
cannulated to the injector.
Figure 2. Representative traces of IOP
Changes in treated eyes with different
crosslinkers.  Every  vertical  square
correspond to 5 mmHg.
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1069with BSS, viscoelastic (hyaluronic acid 2%) was applied to
the  endothelial  surface  to  avoid  mechanical  endothelial
damage  then  a  coverslip  was  applied.  Preparation  was
mounted  in  a  microscope  and  photographed,  cells  were
counted  using  Imagej  NIH  sofware,  celular  damage  was
calculated  from  the  percent  of  cells  with  morphological
abnormalities or cell loss, also cellular area and the number
of cells by mm2 were calculated.
Stromal  and  corneal  keratocytes—A  set  of  treated
corneal stromas treated with the different crosslinkers were
fixed  with  10%  formaledhyde  and  processed  for  optical
microscopy; keratocytes were counted by field.
Statistical  analysis:  In  most  instances,  the  statistical
significance of comparisons was established with a paired
Student’s t-test. Ocular rigidity, endothelial cells counts were
compared  by  one-way  ANOVA  (ANOVA).  Statistically
significant  comparisons  were  established  by  the  Kruskal–
Wallis test using SigmaStat (Systat Software Chicago, IL).
RESULTS
Pressure-volume measurements: Increase of the volume in
porcine eyes led to a increase in IOP, in crosslinked corneas
higher IOP is observed when the volume is increased volume.
At  200  µl  of  volume  the  eyes  with  genipin  had  an  IOP
19.3±1.3 mmHg, UV-CLX 18.8±1.25 mmHg, glutaraldehyde
23.9±1.4 mmHg, and controls14.7±1.4 mmHg (p<0.001), At
400  µl  IOP  was  genipin  30.0±1.8  mmHg,  UV-CLX
26.05±2.3  mmHg,  glutaraldehyde  37.4±2.2  mmHg,  and
controls 18.7±2.19 mmHg (p<0.001). Figure 2 shows typical
traces of eyes treated with diferents crosslinkings.
Ocular rigidity calculated as the ratio of exponential fit
between  IOP  and  volume  according  to  the  Friedenwald
equation  was  genipin  0.0078  mmHg/μl,  UVCRX
0.0065  mmHg/μl,  glutaraldehyde  0.0092  mmHg/μl,  and
0.0046 mmHg/μl for control eyes. Figure 3 shows the curves
of  the  relation  pressure  volume  between  diferents
crosslinkers.
Endothelial cell damage: The cell damage was evaluated with
alizarin red who stain the injured cells and the intercellular
spaces. With this criteria each photograph was analyzed in all
groups. In the Genipin group the endothelial cell damage was
9.4±1.5%, UV riboflavin was 10.35±1.7%, Glutaraldehyde
group was 40.16± 6.23%, and control was 5.91±1.8%.
There was no difference between Genipin versus UV-
CLX versus Control (Figure 4).
Cells by mm2: This area was used to analyze the amount of
cells destroyed by each crosslinker.
The numbers of cells by mm2 were genipin 2,787±80
cells/mm2,  UV  riboflavin  2,526±109  cells/mm2,
Glutaraldehide 2,108±153 cells /mm2, and control 2,790±50
cells/mm2.
There was significant difference between genipin versus
UV riboflavin (p 0.008) and between genipin, UV riboflavin
versus glutaraldehyde.
Cellular area: Cellular area studies the morphology of cells
in the different crosslinkers groups. In genipin group were
277±8  µm2/cells,  UV  riboflavin  296±9  µm2/cell,
glutaraldehyde 326±16.6 µm2/cell, and control 288±7 µm2/
cell.
Figure 3. Relationship pressure-volume
between different crosslinkers.
Molecular Vision 2012; 18:1068-1073 <http://www.molvis.org/molvis/v18/a113> © 2012 Molecular Vision
1070In morphological analysis occasional cells with edema
and with granules were observed in the UV riboflavin group
(Figure  5)  and  cellular  lysis  was  observed  in  the
glutaraldehyde group.
A reduction of keratocytes was observed in the UVCRX
group (40±5 cells by field) in comparison with Control (70±10
cells  by  field),  genipin  (72±8  cells  by  field)  and
glutaraldehyde (64±9 cells by field; Figure 6).
DISCUSSION
Corneal crosslinking have emerged as a novel strategy in the
management of corneal ectasia, keratoconous, and ectasia
post lasik. Currently UV-CLX have improved corneal rigidity
Figure  4.  Endothelial  change  with
different crosslinkers.
Figure 5. Histological Effect in corneal
endothelium with different crosslinkers.
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1071thus reducing the progression of the disease but UV toxicity
and long-term effects not only to the cornea but also in the
lens and retina are still questionable, so approachs that avoid
UV are required.
This study compared the result of diferents crosslinkers
as well as the cytotoxic effects in the endothelial cells. The
crosslinking effect in the whole eye model is similar between
genipin and UV-CLX under physiologic conditions . Maximal
effect is obtained with glutaraldehide the gold standard for
crosslinking in vitro unfortunately the most toxical for all
cells.  In  this  study  we  compared  the  crosslinkers  with  a
methodology, quite more similar to a in vivo situation to
determinate the changes in the ocular rigidity.
Genipin, a natural compound with crosslinker properties
in the cornea, showed a little more of increase in ocular rigidity
and  their  effect  was  similar  in  corneas  with  or  without
epithelium  (data  not  shown)  with  similar  biomechanical
effects, this could be benefical since epithelial deffects can
induce more pain in the post operative and increases the risk
of infection so a crosslinking system with a intact epithelium
is ideal as with minimal toxicity in comparison with the UV
CRX crosslinking method.
The cytotoxic effect in the endothelial cells is similar
between  UVCRX  and  Genipin  in  percent  of  cell  damage
(10.3%  versus  9.4%)  but  was  superior  to  control  corneas
5.9%, with no diference in cell damage between the different
treatments but there was a slightly difference between the
cellular area between treatments with a increase of the area in
UV-CLX, this changes could be due to the UV energy.
In  corneal  keratocytes  a  reduction  of  the  cells  were
observed  in  the  UVCRX  group,  this  effect  have  been
demonstrated previously in other studies [8].
In order for genipin to be therapeutically viable needs to
shown an acceptable biocompatibility profile, a concern could
be  the  effect  of  the  genipin  in  the  endothelial  cells,
morphological changes such as cytoplasmatic foaminess and
vacuole  formation  observed  occasionally  in  the  UVCLX
group could reflect temporal changes of the stress to these
cells that can recover from this radiation [9].
These effects were not observed in the genipin treated
corneas,  as  observed  endothelial  cells  have  lower  area  in
genipin treated cornea in comparison to UVCRX, reflecting
less swelling of this endothelial cells, in fact genipin have
showed a protective and anti apoptotic effect by the inhibition
of the NF-KappaB in hepatic cells [10], this mechanism in
described in the induction of apoptosis in corneal endothelial
cells [11]. Also genipin showed a protection of the retinal
ganglion cells in oxidative stress models [12] other mecanism
in the damage of the corneal endothelium in pathologies as a
Fuchs  endothelial  corneal  distrophy  [13],  so  one  might
consider that the toxical effects to endothelium is minimal and
could consider that could be protective for the endothelium,
despite that this was not the objective of this study we found
less toxicity in the genipin treated corneas as showed in this
study.
In conclusion, we found that Genipin was similar to UV-
CLX in the crosslinking of porcine corneas in the model of
whole eye. However the Genipin could be applied to corneas
Figure  6.  Keratocyte  change  with
different crosslinkers.
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1072with intact epithelium and their effect to the endothelium is
minimal deserving more studies.
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